Evidence map›Paper›PMID 28787641›Full record

ReviewCurrent opinion in biotechnology2018

Functions and emerging applications of bacteriocins.

Michael L Chikindas, Richard Weeks, Djamel Drider, Vladimir A Chistyakov, Leon Mt Dicks

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in biotechnology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 225 papers.

0numbers the graph read from it
0cells of the map it votes in
225citing papers in PubMed
50.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

225 citing papers in PubMed, 556 citations in OpenAlex.

  1. Trial
  2. From predicted bacteriocins to ecological function.Current research in microbial sciences · 2026
    Review
  3. Article
  4. Pacin, a novel bacteriocin fromMicrobiology spectrum · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Expression of Enterocin A in Saccharomyces cerevisiae.Probiotics and antimicrobial proteins · 2026
    Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Bacteriocins fromFrontiers in microbiology · 2026
    Review
  18. Article
  19. Article
  20. Article

165 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 4 countries.

Michael L ChikindasHealth Promoting Naturals Laboratory, School of Environmental and Biological Sciences, Rutgers State University, 65 Dudley Road, New Brunswick, NJ 08901, USA; Center for Digestive Health, New Jersey Institute for Food, Nutrition and Health, 61 Dudley Road, New Brunswick, NJ 08901, USA. Electronic address: tchikind@sebs.rutgers.edu.
Richard WeeksHealth Promoting Naturals Laboratory, School of Environmental and Biological Sciences, Rutgers State University, 65 Dudley Road, New Brunswick, NJ 08901, USA.
Djamel DriderUniversité de Lille, EA 7394 - ICV - Institut Charles Viollette, 59000 Lille, France.
Vladimir A ChistyakovD. I. Ivanovsky Academy of Biology and Biotechnology, Southern Federal University, Rostov-on-Don 344090, Prospekt Stachki 194/1, Russia.
Leon Mt DicksDepartment of Microbiology, Stellenbosch University, 7600 Stellenbosch, South Africa.
Rutgers, The State University of New Jersey · USInstitut Charles Viollette · FRSouthern Federal University · RUStellenbosch University · ZA

Funding

Synthetic AMPs that Control Biofilms of Gram-variable PathogensR21AI126053 · NIAID · RUTGERS, THE STATE UNIV OF N.J. · PI CHIKINDAS, MICHAEL, UHRICH, KATHRYN ELIZABETH · 2016 to 2017
$421k
NIAID NIH HHS R21 AI126053
6 · The paper itself

Abstract

Bacteriocins, defined as ribosomally synthesized antimicrobial peptides, have traditionally been used as food preservatives, either added or produced by starter cultures during fermentation. In-depth studies of a select few bacteriocins opened exiting new research fields and broadened the application of these antimicrobial peptides. The possibility of developing bacteriocins into next generation antibiotics, accompanied with the rapid development in genetics and nanotechnology, paves the way to even more fascinating applications such as novel carrier molecules (delivery systems) and the treatment of cancer. Also, some bacteriocins are found to regulate quorum sensing which suggests novel applications for this group of substances. While there is some interesting translational research on bacteriocins from Gram-negative bacteria, the majority of application-oriented studies are focused on bacteriocins from Gram-positive microorganisms, mostly lactic acid bacteria. The applications of bacteriocins are expanding from food to human health.

Indexed as

BacteriocinsFoodFood PreservationHealthHumansMicrobial ViabilityBacteriocins

Identifiers

PMID28787641
PMCPMC5799035
OpenAlexW2743823731

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.